Charles Alexis Maxime Billard
About Charles Alexis Maxime Billard
Data last updated:
Charles Alexis Maxime Billard was a Director at Sanofi-Synthelabo (India) Private Limited (2018–2020), Director at Sanofi India Limited (2018–2022) and Director at Sanofi Animal Health India Private Limited (from 2018), and held 1 more directorship. The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sanofi-Synthelabo (India) Private Limited U24230MH2002PTC137682 | Director | 12 Jul 2018 | 2002 | ₹729 Cr (FY 2020) | Amalgamated |
 Sanofi India Limited L24239MH1956PLC009794 | Director | 01 Jul 2018 | 1956 | ₹2,916 Cr (FY 2024) | Active |
 Sanofi Animal Health India Private Limited U24232MH2008PTC260334 | Director | 05 Jul 2018 | 2008 | ₹3.1 Lakh (FY 2018) | Strike Off |
| Genzyme India Private Limited U40300MH2007FTC256223 | Director | 12 Jul 2018 | 2007 | ₹50 Lakh (FY 2018) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Charles Alexis Maxime Billard
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Charles Alexis Maxime Billard
Charles Alexis Maxime Billard was first appointed on 01 Jul 2018 as Director at Sanofi India Limited.
Charles Alexis Maxime Billard held 4 earlier board appointments: Sanofi-Synthelabo (India) Private Limited (Director, 12 Jul 2018 to 23 Oct 2020); Sanofi India Limited (Director, 01 Jul 2018 to 03 Nov 2022); Sanofi Animal Health India Private Limited (Director, from 05 Jul 2018); Genzyme India Private Limited (Director, from 12 Jul 2018).